CL PHARMA
Last board
1 director, 1 auditor, last change in 2021Director
since 07-12-2020
also on the board of 9 other companies
listed in the 2021 annual accounts, filed on 22-06-2022
Statutory auditor, permanent representative Jorion Axel
appointed by deed of 25-01-2021
Mandates through the years
3 names, the dashed line is todayBoardEarliermandate already running before its first mention
Mandates as a list
- Geert REYNIERS
- Director, from 07-12-2020 to date
- KPMG Réviseurs d'Entreprises SCRL
- Statutory auditor, from 07-12-2020 to date
- Sophie Lukasik
- Manager, until 25-01-2021
Control
Consolidating parent
Equity €164.7m
Loss €242,114 in 2025 (loss €60,057 in 2024)
Checked score 95
Source: parent in own accounts 2021
consolidates
This company
CL PHARMA
Equity €116,797
Loss €49,182 in 2021
Capital
- Contribution
- €100,000
- Source
- 2021 annual accounts
Owners through the years
as the annual accounts name themOwners as a list
- Multipharma
- MULTIPHARMA GROUP
Source: shareholder structure in its own accounts, parent in its own accounts
Capital transactions
Shareholders according to the deeds
Stated in the deed
deed of 30-06-2022 ↗
- MULTIPHARMA (BE 0866.855.346) all shares